NORTH AMERICA SURGICAL AND MEDICAL DEVICES MARKET FORECAST 2017-2026
KEY FINDINGS
The North America surgical and medical device market collected the highest proceeds of $ 206537 million in 2016. With an expected CAGR growth of 5.98%, the market is all set to expand further over the forecast period of 2017-2026, generating $ 368016 million.
MARKET INSIGHTS
The U.S and Canada markets predominate this region, of which the U.S is predicted to lead the overall North American medical and surgical device market. Increasing lifestyle oriented diseases, technological advancement and an increase in healthcare spending are few of the critical factors that are responsible for the market growth. The medical device industry relies upon several small industries such as telecommunications, microelectronics, biotechnology, instrumentation, and software development and in this regard, the United States holds a competitive advantage over other regions.
COMPETITIVE INSIGHTS
Major players in the North American medical and surgical device market are 3M Company, Boston Scientific, Zimmer Holdings, Thermo Fisher Scientific, Agilent Technologies, Abbott Laboratories, Baxter International, Johnson & Johnson, Siemens Healthcare, Bayer, Beckton, Dickinson, And Co, Novartis, Philips Healthcare, MedtronicOlympus Corporation, Roche Diagnostics,Endologix Inc, Teleflex, Danaher, Cryolife Inc, Fresenius, Toshiba Medical Systems Corp (Canon),Smith & Nephew, Cardinal Health, Stryker Corp, Halyard Health Inc., Ge Healthcare and Depuy Synthes.
The North America surgical and medical device market collected the highest proceeds of $ 206537 million in 2016. With an expected CAGR growth of 5.98%, the market is all set to expand further over the forecast period of 2017-2026, generating $ 368016 million.
MARKET INSIGHTS
The U.S and Canada markets predominate this region, of which the U.S is predicted to lead the overall North American medical and surgical device market. Increasing lifestyle oriented diseases, technological advancement and an increase in healthcare spending are few of the critical factors that are responsible for the market growth. The medical device industry relies upon several small industries such as telecommunications, microelectronics, biotechnology, instrumentation, and software development and in this regard, the United States holds a competitive advantage over other regions.
COMPETITIVE INSIGHTS
Major players in the North American medical and surgical device market are 3M Company, Boston Scientific, Zimmer Holdings, Thermo Fisher Scientific, Agilent Technologies, Abbott Laboratories, Baxter International, Johnson & Johnson, Siemens Healthcare, Bayer, Beckton, Dickinson, And Co, Novartis, Philips Healthcare, MedtronicOlympus Corporation, Roche Diagnostics,Endologix Inc, Teleflex, Danaher, Cryolife Inc, Fresenius, Toshiba Medical Systems Corp (Canon),Smith & Nephew, Cardinal Health, Stryker Corp, Halyard Health Inc., Ge Healthcare and Depuy Synthes.
1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. DRUG DELIVERY DEVICES HOLDS THE LARGEST MARKET SHARE IN TERMS OF TECHNOLOGY
3.2.2. AMBULATORY SURGERY CENTERS (ASC) ARE THE MARKET LEADERS IN TERMS OF END USERS
4. MARKET DETERMINANTS
4.1. MARKET DRIVERS
4.1.1. PROLONGED LIFE EXPECTANCY
4.1.2. INCREASE IN DEMAND FOR MEDICAL DEVICE TECHNOLOGIES
4.1.3. LEGISLATIVE ALTERATIONS AND OTHER INGENUITIES
4.2. MARKET RESTRAINTS
4.2.1. HIGH COSTS OF MEDICAL AND SURGICAL DEVICES
4.2.2. EXCISE DUTY ADDED TO THE COST OF MEDICAL DEVICES
5. MARKET SEGMENTATION
5.1. MARKET BY TECHNOLOGY 2017-2026
5.1.1. DRUG DELIVERY DEVICES
5.1.1.1. INFUSION SYSTEMS AND INJECTABLE
5.1.1.2. NEEDLE-FREE INJECTIONS/TRANSDERMAL SYSTEMS AND OTHERS
5.1.1.3. INHALATION SYSTEMS
5.1.2. UROLOGY AND RENAL
5.1.2.1. RENAL DIALYSIS DEVICES
5.1.2.2. LITHOTRIPTERS
5.1.2.3. INCONTINENCE DEVICES
5.1.3. IN VITRO DIAGNOSTICS
5.1.3.1. CLINICAL CHEMISTRY
5.1.3.2. IMMUNOCHEMISTRY
5.1.3.3. MOLECULAR DIAGNOSTICS
5.1.3.4. HEMATOLOGY/HEMOSTASIS
5.1.3.5. POINT-OF-CARE TESTING
5.1.4. ORTHOPEDICS AND SPINE
5.1.4.1. RECONSTRUCTIVE IMPLANTS
5.1.4.2. SPINAL IMPLANTS
5.1.4.3. TRAUMA FIXATION DEVICES
5.1.4.4. ORTHOPEDIC ROBOTIC SYSTEMS
5.1.5. IMAGING DEVICES
5.1.5.1. X-RAY SYSTEMS
5.1.5.2. ULTRASOUND SYSTEMS
5.1.5.3. COMPUTED TOMOGRAPHY (CT)
5.1.5.4. MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS
5.1.5.5. CLINICAL/POINT OF CARE
5.1.5.6. NUCLEAR MEDICINE/POSITRON EMISSION TOMOGRAPHY (PET)
5.1.5.7. INTERVENTIONAL RADIOLOGY
5.1.5.8. LASER IMAGING
5.1.6. CARDIOVASCULAR DEVICES
5.1.6.1. CARDIAC RHYTHM MANAGEMENT
5.1.6.2. TRANSCATHETER TECHNOLOGIES
5.1.7. ENDOSCOPY
5.1.7.1. RIGID ENDOSCOPIC
5.1.7.2. FLEXIBLE ENDOSCOPIC
5.2. MARKET BY END USER 2017-2026
5.2.1. ASCS
5.2.2. HOSPITALS
5.2.3. PHYSICIANS' OFFICES
6. KEY ANALYTICS
6.1. PORTER’S FIVE FORCES ANALYSIS
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTES
6.1.3. BARGAINING POWER OF BUYERS
6.1.4. BARGAINING POWER OF SUPPLIERS
6.1.5. THREAT OF RIVALRY
6.2. VALUE CHAIN ANALYSIS
6.3. KEY BUYING CRITERIA
7. GEOGRAPHICAL ANALYSIS
7.1. NORTH AMERICA
7.1.1. UNITED STATES
7.1.2. CANADA
8. COMPANY PROFILES
8.1. 3M
8.1.1. COMPANY OVERVIEW
8.1.2. PRODUCT PORTFOLIO
8.1.3. STRATEGIC INITIATIVES
8.2. ABBOTT LABORATORIES
8.2.1. COMPANY OVERVIEW
8.2.2. PRODUCT PORTFOLIO
8.2.3. STRATEGIC INITIATIVES
8.3. AGILENT TECHNOLOGIES
8.3.1. COMPANY OVERVIEW
8.3.2. PRODUCT PORTFOLIO
8.3.3. STRATEGIC INITIATIVES
8.4. BAYER
8.4.1. COMPANY OVERVIEW
8.4.2. PRODUCT PORTFOLIO
8.4.3. STRATEGIC INITIATIVES
8.5. BAXTER INTERNATIONAL
8.5.1. COMPANY OVERVIEW
8.5.2. PRODUCT PORTFOLIO
8.5.3. STRATEGIC INITIATIVES
8.6. BECKTON, DICKINSON, AND CO.
8.6.1. COMPANY OVERVIEW
8.6.2. PRODUCT PORTFOLIO
8.6.3. STRATEGIC INITIATIVES
8.7. BOSTON SCIENTIFIC
8.7.1. COMPANY OVERVIEW
8.7.2. PRODUCT PORTFOLIO
8.7.3. STRATEGIC INITIATIVES
8.8. CARDINAL HEALTH
8.8.1. COMPANY OVERVIEW
8.8.2. PRODUCT PORTFOLIO
8.8.3. STRATEGIC INITIATIVES
8.9. CRYOLIFE INC.
8.9.1. COMPANY OVERVIEW
8.9.2. PRODUCT PORTFOLIO
8.9.3. STRATEGIC INITIATIVES
8.10. DANAHER
8.10.1. COMPANY OVERVIEW
8.10.2. PRODUCT PORTFOLIO
8.10.3. STRATEGIC INITIATIVES
8.11. DEPUY SYNTHES
8.11.1. COMPANY OVERVIEW
8.11.2. PRODUCT PORTFOLIO
8.11.3. STRATEGIC INITIATIVES
8.12. ENDOLOGIX INC.
8.12.1. PRODUCT PORTFOLIO
8.12.2. STRATEGIC INITIATIVES
8.13. FRESENIUS
8.13.1. COMPANY OVERVIEW
8.13.2. PRODUCT PORTFOLIO
8.13.3. STRATEGIC INITIATIVES
8.14. GE HEALTHCARE
8.14.1. COMPANY OVERVIEW
8.14.2. PRODUCT PORTFOLIO
8.14.3. STRATEGIC INITIATIVES
8.15. HALYARD HEALTH, INC.
8.15.1. COMPANY OVERVIEW
8.15.2. PRODUCT PORTFOLIO
8.15.3. STRATEGIC INITIATIVES
8.16. JOHNSON & JOHNSON
8.16.1. COMPANY OVERVIEW
8.16.2. PRODUCT PORTFOLIO
8.16.3. STRATEGIC INITIATIVES
8.17. MEDTRONIC
8.17.1. COMPANY OVERVIEW
8.17.2. PRODUCT PORTFOLIO
8.17.3. STRATEGIC INITIATIVES
8.18. NOVARTIS
8.18.1. COMPANY OVERVIEW
8.18.2. PRODUCT PORTFOLIO
8.18.3. STRATEGIC INITIATIVES
8.19. OLYMPUS CORPORATION
8.19.1. COMPANY OVERVIEW
8.19.2. PRODUCT PORTFOLIO
8.19.3. STRATEGIC INITIATIVES
8.20. PHILIPS HEALTHCARE
8.20.1. COMPANY OVERVIEW
8.20.2. PRODUCT PORTFOLIO
8.20.3. STRATEGIC INITIATIVES
8.21. ROCHE DIAGNOSTICS
8.21.1. COMPANY OVERVIEW
8.21.2. PRODUCT PORTFOLIO
8.21.3. STRATEGIC INITIATIVES
8.22. SIEMENS HEALTHCARE
8.22.1. COMPANY OVERVIEW
8.22.2. PRODUCT PORTFOLIO
8.22.3. STRATEGIC INITIATIVES
8.23. SMITH & NEPHEW
8.23.1. COMPANY OVERVIEW
8.23.2. PRODUCT PORTFOLIO
8.23.3. STRATEGIC INITIATIVES
8.24. STRYKER CORP.
8.24.1. COMPANY OVERVIEW
8.24.2. PRODUCT PORTFOLIO
8.24.3. STRATEGIC INITIATIVES
8.25. TELEFLEX
8.25.1. COMPANY OVERVIEW
8.25.2. PRODUCT PORTFOLIO
8.25.3. STRATEGIC INITIATIVES
8.26. THERMO FISHER SCIENTIFIC
8.26.1. COMPANY OVERVIEW
8.26.2. PRODUCT PORTFOLIO
8.26.3. STRATEGIC INITIATIVES
8.27. TOSHIBA MEDICAL SYSTEMS CORP. (CANON)
8.27.1. COMPANY OVERVIEW
8.27.2. PRODUCT PORTFOLIO
8.27.3. STRATEGIC INITIATIVES
8.28. ZIMMER HOLDINGS
8.28.1. COMPANY OVERVIEW
8.28.2. PRODUCT PORTFOLIO
8.28.3. STRATEGIC INITIATIVES
TABLE LIST
TABLE 1 NORTH AMERICA SURGICAL AND MEDICAL DEVICES MARKET 2017-2026 ($ MILLION)
TABLE 2 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET, BY TECHNOLOGY 2017-2026 ($ MILLION)
TABLE 3 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN DRUG DELIVERY DEVICES 2017-2026 ($ MILLION)
TABLE 4 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN INFUSION SYSTEMS AND INJECTABLES, 2017-2026 ($ MILLION)
TABLE 5 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN NEEDLE-FREE INJECTIONS, 2017-2026 ($ MILLION)
TABLE 6 MAJOR DRUGS ADMINISTERED THROUGH TRANSDERMAL DRUG DELIVERY TECHNIQUES
TABLE 7 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET INHALATION SYSTEMS, 2017-2026 ($ MILLION)
TABLE 8 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN UROLOGY AND RENAL 2017-2026 ($ MILLION)
TABLE 9 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN RENAL DIALYSIS DEVICES, 2017-2026 ($ MILLION)
TABLE 10 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN LITHOTRIPTERS, 2017-2026 ($ MILLION)
TABLE 11 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN INCONTINENCE DEVICES, 2017-2026 ($ MILLION)
TABLE 12 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN 2017-2026 ($ MILLION)
TABLE 13 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN CLINICAL CHEMISTRY 2017-2026 ($ MILLION)
TABLE 14 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN IMMUNOCHEMISTRY 2017-2026 ($ MILLION)
TABLE 15 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN MOLECULAR DIAGNOSTICS 2017-2026 ($ MILLION)
TABLE 16 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN HEMATOLOGY/HEMOSTASIS 2017-2026 ($ MILLION)
TABLE 17 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN POINT-OF-CARE TESTING 2017-2026 ($ MILLION)
TABLE 18 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN ORTHOPAEDICS AND SPINE 2017-2026 ($ MILLION)
TABLE 19 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN RECONSTRUCTIVE IMPLANTS 2017-2026 ($ MILLION)
TABLE 20 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN SPINAL IMPLANTS 2017-2026 ($ MILLION)
TABLE 21 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN TRAUMA FIXATION DEVICES 2017-2026 ($ MILLION)
TABLE 22 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN ORTHOPEDIC ROBOTIC SYSTEMS 2017-2026 ($ MILLION)
TABLE 23 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN IMAGING DEVICES 2017-2026 ($ MILLION)
TABLE 24 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN X-RAY SYSTEMS 2017-2026 ($ MILLION)
TABLE 25 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN ULTRASOUND SYSTEMS 2017-2026 ($ MILLION)
TABLE 26 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN COMPUTED TOMOGRAPHY (CT) 2017-2026 ($ MILLION)
TABLE 27 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS 2017-2026 ($ MILLION)
TABLE 28 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN CLINICAL/POINT OF CARE 2017-2026 ($ MILLION)
TABLE 29 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN NUCLEAR MEDICINE/POSITRON EMISSION TOMOGRAPHY (PET) 2017-2026 ($ MILLION)
TABLE 30 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN INTERVENTIONAL RADIOLOGY 2017-2026 ($ MILLION)
TABLE 31 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN 2017-2026 ($ MILLION)
TABLE 32 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN CARDIOVASCULAR DEVICES 2017-2026 ($ MILLION)
TABLE 33 ABLATION TYPES AND THEIR MECHANISMS
TABLE 34 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN CARDIAC RHYTHM MANAGEMENT 2017-2026 ($ MILLION)
TABLE 35 ANTI-ARRHYTHMIC DRUG TYPES AND CLINICAL USAGE
TABLE 36 ANTI-ARRHYTHMIC DRUG CLASSIFICATION AND CLINICAL USAGE
TABLE 37 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN TRANSCATHETER TECHNOLOGIES 2017-2026 ($ MILLION)
TABLE 38 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN ENDOSCOPY 2017-2026 ($ MILLION)
TABLE 39 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN RIGID ENDOSCOPIC 2017-2026 ($ MILLION)
TABLE 40 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN FLEXIBLE ENDOSCOPIC 2017-2026 ($ MILLION)
TABLE 41 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET, BY END-USER 2017-2026 ($MILLION)
TABLE 42 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN ASCS, 2017-2026 ($MILLION)
TABLE 43 COMPARISON OF REIMBURSEMENT FOR ASCS, HOSPITAL OUTPATIENT DEPARTMENTS, AND PHYSICIANS OFFICES IN THE US
TABLE 44 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN HOSPITAL, 2017-2026 ($MILLION)
TABLE 45 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN PHYSICIANS OFFICES, 2017-2026 ($MILLION)
TABLE 46 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET, 2017-2026 ($ MILLION)
TABLE 47 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET, BY COUNTRIES 2017-2026 ($ MILLION)
FIGURE LIST
FIGURE 1 NORTH AMERICA SURGICAL AND MEDICAL DEVICES MARKET 2017-2026 ($ MILLION)
FIGURE 2 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN DRUG DELIVERY DEVICES 2017-2026 ($ MILLION)
FIGURE 3 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN INFUSION SYSTEMS AND INJECTABLES 2017-2026 ($ MILLION)
FIGURE 4 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN NEEDLE-FREE INJECTIONS 2017-2026 ($ MILLION)
FIGURE 5 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN INHALATION SYSTEMS 2017-2026 ($ MILLION)
FIGURE 6 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN UROLOGY AND RENAL 2017-2026 ($ MILLION)
FIGURE 7 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN RENAL DIALYSIS DEVICES 2017-2026 ($ MILLION)
FIGURE 8 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN LITHOTRIPTERS 2017-2026 ($ MILLION)
FIGURE 9 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN INCONTINENCE DEVICES 2017-2026 ($ MILLION)
FIGURE 10 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN 2017-2026 ($ MILLION)
FIGURE 11 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN CLINICAL CHEMISTRY 2017-2026 ($ MILLION)
FIGURE 12 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN IMMUNOCHEMISTRY 2017-2026 ($ MILLION)
FIGURE 13 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN MOLECULAR DIAGNOSTICS 2017-2026 ($ MILLION)
FIGURE 14 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN HEMATOLOGY/HEMOSTASIS 2017-2026 ($ MILLION)
FIGURE 15 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN POINT-OF-CARE TESTING 2017-2026 ($ MILLION)
FIGURE 16 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN ORTHOPAEDICS AND SPINE 2017-2026 ($ MILLION)
FIGURE 17 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN RECONSTRUCTIVE IMPLANTS 2017-2026 ($ MILLION)
FIGURE 18 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN SPINAL IMPLANTS 2017-2026 ($ MILLION)
FIGURE 19 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN TRAUMA FIXATION DEVICES 2017-2026 ($ MILLION)
FIGURE 20 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN ORTHOPEDIC ROBOTIC SYSTEMS 2017-2026 ($ MILLION)
FIGURE 21 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN IMAGING DEVICES 2017-2026 ($ MILLION)
FIGURE 22 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN X-RAY SYSTEMS 2017-2026 ($ MILLION)
FIGURE 23 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN ULTRASOUND SYSTEMS 2017-2026 ($ MILLION)
FIGURE 24 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN COMPUTED TOMOGRAPHY (CT) 2017-2026 ($ MILLION)
FIGURE 25 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS 2017-2026 ($ MILLION)
FIGURE 26 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN CLINICAL/POINT OF CARE 2017-2026 ($ MILLION)
FIGURE 27 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN NUCLEAR MEDICINE/POSITRON EMISSION TOMOGRAPHY (PET) 2017-2026 ($ MILLION)
FIGURE 28 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN INTERVENTIONAL RADIOLOGY 2017-2026 ($ MILLION)
FIGURE 29 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN 2017-2026 ($ MILLION)
FIGURE 30 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN CARDIOVASCULAR DEVICES 2017-2026 ($ MILLION)
FIGURE 31 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN CARDIAC RHYTHM MANAGEMENT 2017-2026 ($ MILLION)
FIGURE 32 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN TRANSCATHETER TECHNOLOGIES 2017-2026 ($ MILLION)
FIGURE 33 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN ENDOSCOPY 2017-2026 ($ MILLION)
FIGURE 34 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN RIGID ENDOSCOPIC 2017-2026 ($ MILLION)
FIGURE 35 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN FLEXIBLE ENDOSCOPIC 2017-2026 ($ MILLION)
FIGURE 36 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN ASCS 2017-2026 ($MILLION)
FIGURE 37 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN HOSPITAL 2017-2026 ($MILLION)
FIGURE 38 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN PHYSICIANS OFFICES 2017-2026 ($MILLION)
FIGURE 39 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET 2017-2026 ($ MILLION)
FIGURE 40 UNITED STATES SURGICAL AND MEDICAL DEVICE MARKET 2017-2026 ($ MILLION)
FIGURE 41 CANADA SURGICAL AND MEDICAL DEVICE MARKET 2017-2026 ($ MILLION)
COMPANIES MENTIONED
1. 3M COMPANY
2. ABBOTT LABORATORIES
3. AGILENT TECHNOLOGIES
4. BAYER
5. BAXTER INTERNATIONAL
6. BECKTON, DICKINSON, AND CO.
7. BOSTON SCIENTIFIC
8. CARDINAL HEALTH
9. CRYOLIFE INC.
10. DANAHER
11. DEPUY SYNTHES
12. ENDOLOGIX INC.
13. FRESENIUS
14. GE HEALTHCARE
15. HALYARD HEALTH, INC.
16. JOHNSON & JOHNSON
17. MEDTRONIC
18. NOVARTIS
19. OLYMPUS CORPORATION
20. PHILIPS HEALTHCARE
21. ROCHE DIAGNOSTICS
22. SIEMENS HEALTHCARE
23. SMITH & NEPHEW
24. STRYKER CORP.
25. TELEFLEX
26. THERMO FISHER SCIENTIFIC
27. TOSHIBA MEDICAL SYSTEMS CORP. (CANON)
28. ZIMMER HOLDINGS
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. DRUG DELIVERY DEVICES HOLDS THE LARGEST MARKET SHARE IN TERMS OF TECHNOLOGY
3.2.2. AMBULATORY SURGERY CENTERS (ASC) ARE THE MARKET LEADERS IN TERMS OF END USERS
4. MARKET DETERMINANTS
4.1. MARKET DRIVERS
4.1.1. PROLONGED LIFE EXPECTANCY
4.1.2. INCREASE IN DEMAND FOR MEDICAL DEVICE TECHNOLOGIES
4.1.3. LEGISLATIVE ALTERATIONS AND OTHER INGENUITIES
4.2. MARKET RESTRAINTS
4.2.1. HIGH COSTS OF MEDICAL AND SURGICAL DEVICES
4.2.2. EXCISE DUTY ADDED TO THE COST OF MEDICAL DEVICES
5. MARKET SEGMENTATION
5.1. MARKET BY TECHNOLOGY 2017-2026
5.1.1. DRUG DELIVERY DEVICES
5.1.1.1. INFUSION SYSTEMS AND INJECTABLE
5.1.1.2. NEEDLE-FREE INJECTIONS/TRANSDERMAL SYSTEMS AND OTHERS
5.1.1.3. INHALATION SYSTEMS
5.1.2. UROLOGY AND RENAL
5.1.2.1. RENAL DIALYSIS DEVICES
5.1.2.2. LITHOTRIPTERS
5.1.2.3. INCONTINENCE DEVICES
5.1.3. IN VITRO DIAGNOSTICS
5.1.3.1. CLINICAL CHEMISTRY
5.1.3.2. IMMUNOCHEMISTRY
5.1.3.3. MOLECULAR DIAGNOSTICS
5.1.3.4. HEMATOLOGY/HEMOSTASIS
5.1.3.5. POINT-OF-CARE TESTING
5.1.4. ORTHOPEDICS AND SPINE
5.1.4.1. RECONSTRUCTIVE IMPLANTS
5.1.4.2. SPINAL IMPLANTS
5.1.4.3. TRAUMA FIXATION DEVICES
5.1.4.4. ORTHOPEDIC ROBOTIC SYSTEMS
5.1.5. IMAGING DEVICES
5.1.5.1. X-RAY SYSTEMS
5.1.5.2. ULTRASOUND SYSTEMS
5.1.5.3. COMPUTED TOMOGRAPHY (CT)
5.1.5.4. MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS
5.1.5.5. CLINICAL/POINT OF CARE
5.1.5.6. NUCLEAR MEDICINE/POSITRON EMISSION TOMOGRAPHY (PET)
5.1.5.7. INTERVENTIONAL RADIOLOGY
5.1.5.8. LASER IMAGING
5.1.6. CARDIOVASCULAR DEVICES
5.1.6.1. CARDIAC RHYTHM MANAGEMENT
5.1.6.2. TRANSCATHETER TECHNOLOGIES
5.1.7. ENDOSCOPY
5.1.7.1. RIGID ENDOSCOPIC
5.1.7.2. FLEXIBLE ENDOSCOPIC
5.2. MARKET BY END USER 2017-2026
5.2.1. ASCS
5.2.2. HOSPITALS
5.2.3. PHYSICIANS' OFFICES
6. KEY ANALYTICS
6.1. PORTER’S FIVE FORCES ANALYSIS
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTES
6.1.3. BARGAINING POWER OF BUYERS
6.1.4. BARGAINING POWER OF SUPPLIERS
6.1.5. THREAT OF RIVALRY
6.2. VALUE CHAIN ANALYSIS
6.3. KEY BUYING CRITERIA
7. GEOGRAPHICAL ANALYSIS
7.1. NORTH AMERICA
7.1.1. UNITED STATES
7.1.2. CANADA
8. COMPANY PROFILES
8.1. 3M
8.1.1. COMPANY OVERVIEW
8.1.2. PRODUCT PORTFOLIO
8.1.3. STRATEGIC INITIATIVES
8.2. ABBOTT LABORATORIES
8.2.1. COMPANY OVERVIEW
8.2.2. PRODUCT PORTFOLIO
8.2.3. STRATEGIC INITIATIVES
8.3. AGILENT TECHNOLOGIES
8.3.1. COMPANY OVERVIEW
8.3.2. PRODUCT PORTFOLIO
8.3.3. STRATEGIC INITIATIVES
8.4. BAYER
8.4.1. COMPANY OVERVIEW
8.4.2. PRODUCT PORTFOLIO
8.4.3. STRATEGIC INITIATIVES
8.5. BAXTER INTERNATIONAL
8.5.1. COMPANY OVERVIEW
8.5.2. PRODUCT PORTFOLIO
8.5.3. STRATEGIC INITIATIVES
8.6. BECKTON, DICKINSON, AND CO.
8.6.1. COMPANY OVERVIEW
8.6.2. PRODUCT PORTFOLIO
8.6.3. STRATEGIC INITIATIVES
8.7. BOSTON SCIENTIFIC
8.7.1. COMPANY OVERVIEW
8.7.2. PRODUCT PORTFOLIO
8.7.3. STRATEGIC INITIATIVES
8.8. CARDINAL HEALTH
8.8.1. COMPANY OVERVIEW
8.8.2. PRODUCT PORTFOLIO
8.8.3. STRATEGIC INITIATIVES
8.9. CRYOLIFE INC.
8.9.1. COMPANY OVERVIEW
8.9.2. PRODUCT PORTFOLIO
8.9.3. STRATEGIC INITIATIVES
8.10. DANAHER
8.10.1. COMPANY OVERVIEW
8.10.2. PRODUCT PORTFOLIO
8.10.3. STRATEGIC INITIATIVES
8.11. DEPUY SYNTHES
8.11.1. COMPANY OVERVIEW
8.11.2. PRODUCT PORTFOLIO
8.11.3. STRATEGIC INITIATIVES
8.12. ENDOLOGIX INC.
8.12.1. PRODUCT PORTFOLIO
8.12.2. STRATEGIC INITIATIVES
8.13. FRESENIUS
8.13.1. COMPANY OVERVIEW
8.13.2. PRODUCT PORTFOLIO
8.13.3. STRATEGIC INITIATIVES
8.14. GE HEALTHCARE
8.14.1. COMPANY OVERVIEW
8.14.2. PRODUCT PORTFOLIO
8.14.3. STRATEGIC INITIATIVES
8.15. HALYARD HEALTH, INC.
8.15.1. COMPANY OVERVIEW
8.15.2. PRODUCT PORTFOLIO
8.15.3. STRATEGIC INITIATIVES
8.16. JOHNSON & JOHNSON
8.16.1. COMPANY OVERVIEW
8.16.2. PRODUCT PORTFOLIO
8.16.3. STRATEGIC INITIATIVES
8.17. MEDTRONIC
8.17.1. COMPANY OVERVIEW
8.17.2. PRODUCT PORTFOLIO
8.17.3. STRATEGIC INITIATIVES
8.18. NOVARTIS
8.18.1. COMPANY OVERVIEW
8.18.2. PRODUCT PORTFOLIO
8.18.3. STRATEGIC INITIATIVES
8.19. OLYMPUS CORPORATION
8.19.1. COMPANY OVERVIEW
8.19.2. PRODUCT PORTFOLIO
8.19.3. STRATEGIC INITIATIVES
8.20. PHILIPS HEALTHCARE
8.20.1. COMPANY OVERVIEW
8.20.2. PRODUCT PORTFOLIO
8.20.3. STRATEGIC INITIATIVES
8.21. ROCHE DIAGNOSTICS
8.21.1. COMPANY OVERVIEW
8.21.2. PRODUCT PORTFOLIO
8.21.3. STRATEGIC INITIATIVES
8.22. SIEMENS HEALTHCARE
8.22.1. COMPANY OVERVIEW
8.22.2. PRODUCT PORTFOLIO
8.22.3. STRATEGIC INITIATIVES
8.23. SMITH & NEPHEW
8.23.1. COMPANY OVERVIEW
8.23.2. PRODUCT PORTFOLIO
8.23.3. STRATEGIC INITIATIVES
8.24. STRYKER CORP.
8.24.1. COMPANY OVERVIEW
8.24.2. PRODUCT PORTFOLIO
8.24.3. STRATEGIC INITIATIVES
8.25. TELEFLEX
8.25.1. COMPANY OVERVIEW
8.25.2. PRODUCT PORTFOLIO
8.25.3. STRATEGIC INITIATIVES
8.26. THERMO FISHER SCIENTIFIC
8.26.1. COMPANY OVERVIEW
8.26.2. PRODUCT PORTFOLIO
8.26.3. STRATEGIC INITIATIVES
8.27. TOSHIBA MEDICAL SYSTEMS CORP. (CANON)
8.27.1. COMPANY OVERVIEW
8.27.2. PRODUCT PORTFOLIO
8.27.3. STRATEGIC INITIATIVES
8.28. ZIMMER HOLDINGS
8.28.1. COMPANY OVERVIEW
8.28.2. PRODUCT PORTFOLIO
8.28.3. STRATEGIC INITIATIVES
TABLE LIST
TABLE 1 NORTH AMERICA SURGICAL AND MEDICAL DEVICES MARKET 2017-2026 ($ MILLION)
TABLE 2 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET, BY TECHNOLOGY 2017-2026 ($ MILLION)
TABLE 3 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN DRUG DELIVERY DEVICES 2017-2026 ($ MILLION)
TABLE 4 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN INFUSION SYSTEMS AND INJECTABLES, 2017-2026 ($ MILLION)
TABLE 5 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN NEEDLE-FREE INJECTIONS, 2017-2026 ($ MILLION)
TABLE 6 MAJOR DRUGS ADMINISTERED THROUGH TRANSDERMAL DRUG DELIVERY TECHNIQUES
TABLE 7 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET INHALATION SYSTEMS, 2017-2026 ($ MILLION)
TABLE 8 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN UROLOGY AND RENAL 2017-2026 ($ MILLION)
TABLE 9 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN RENAL DIALYSIS DEVICES, 2017-2026 ($ MILLION)
TABLE 10 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN LITHOTRIPTERS, 2017-2026 ($ MILLION)
TABLE 11 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN INCONTINENCE DEVICES, 2017-2026 ($ MILLION)
TABLE 12 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN 2017-2026 ($ MILLION)
TABLE 13 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN CLINICAL CHEMISTRY 2017-2026 ($ MILLION)
TABLE 14 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN IMMUNOCHEMISTRY 2017-2026 ($ MILLION)
TABLE 15 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN MOLECULAR DIAGNOSTICS 2017-2026 ($ MILLION)
TABLE 16 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN HEMATOLOGY/HEMOSTASIS 2017-2026 ($ MILLION)
TABLE 17 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN POINT-OF-CARE TESTING 2017-2026 ($ MILLION)
TABLE 18 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN ORTHOPAEDICS AND SPINE 2017-2026 ($ MILLION)
TABLE 19 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN RECONSTRUCTIVE IMPLANTS 2017-2026 ($ MILLION)
TABLE 20 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN SPINAL IMPLANTS 2017-2026 ($ MILLION)
TABLE 21 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN TRAUMA FIXATION DEVICES 2017-2026 ($ MILLION)
TABLE 22 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN ORTHOPEDIC ROBOTIC SYSTEMS 2017-2026 ($ MILLION)
TABLE 23 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN IMAGING DEVICES 2017-2026 ($ MILLION)
TABLE 24 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN X-RAY SYSTEMS 2017-2026 ($ MILLION)
TABLE 25 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN ULTRASOUND SYSTEMS 2017-2026 ($ MILLION)
TABLE 26 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN COMPUTED TOMOGRAPHY (CT) 2017-2026 ($ MILLION)
TABLE 27 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS 2017-2026 ($ MILLION)
TABLE 28 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN CLINICAL/POINT OF CARE 2017-2026 ($ MILLION)
TABLE 29 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN NUCLEAR MEDICINE/POSITRON EMISSION TOMOGRAPHY (PET) 2017-2026 ($ MILLION)
TABLE 30 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN INTERVENTIONAL RADIOLOGY 2017-2026 ($ MILLION)
TABLE 31 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN 2017-2026 ($ MILLION)
TABLE 32 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN CARDIOVASCULAR DEVICES 2017-2026 ($ MILLION)
TABLE 33 ABLATION TYPES AND THEIR MECHANISMS
TABLE 34 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN CARDIAC RHYTHM MANAGEMENT 2017-2026 ($ MILLION)
TABLE 35 ANTI-ARRHYTHMIC DRUG TYPES AND CLINICAL USAGE
TABLE 36 ANTI-ARRHYTHMIC DRUG CLASSIFICATION AND CLINICAL USAGE
TABLE 37 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN TRANSCATHETER TECHNOLOGIES 2017-2026 ($ MILLION)
TABLE 38 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN ENDOSCOPY 2017-2026 ($ MILLION)
TABLE 39 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN RIGID ENDOSCOPIC 2017-2026 ($ MILLION)
TABLE 40 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN FLEXIBLE ENDOSCOPIC 2017-2026 ($ MILLION)
TABLE 41 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET, BY END-USER 2017-2026 ($MILLION)
TABLE 42 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN ASCS, 2017-2026 ($MILLION)
TABLE 43 COMPARISON OF REIMBURSEMENT FOR ASCS, HOSPITAL OUTPATIENT DEPARTMENTS, AND PHYSICIANS OFFICES IN THE US
TABLE 44 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN HOSPITAL, 2017-2026 ($MILLION)
TABLE 45 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN PHYSICIANS OFFICES, 2017-2026 ($MILLION)
TABLE 46 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET, 2017-2026 ($ MILLION)
TABLE 47 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET, BY COUNTRIES 2017-2026 ($ MILLION)
FIGURE LIST
FIGURE 1 NORTH AMERICA SURGICAL AND MEDICAL DEVICES MARKET 2017-2026 ($ MILLION)
FIGURE 2 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN DRUG DELIVERY DEVICES 2017-2026 ($ MILLION)
FIGURE 3 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN INFUSION SYSTEMS AND INJECTABLES 2017-2026 ($ MILLION)
FIGURE 4 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN NEEDLE-FREE INJECTIONS 2017-2026 ($ MILLION)
FIGURE 5 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN INHALATION SYSTEMS 2017-2026 ($ MILLION)
FIGURE 6 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN UROLOGY AND RENAL 2017-2026 ($ MILLION)
FIGURE 7 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN RENAL DIALYSIS DEVICES 2017-2026 ($ MILLION)
FIGURE 8 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN LITHOTRIPTERS 2017-2026 ($ MILLION)
FIGURE 9 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN INCONTINENCE DEVICES 2017-2026 ($ MILLION)
FIGURE 10 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN 2017-2026 ($ MILLION)
FIGURE 11 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN CLINICAL CHEMISTRY 2017-2026 ($ MILLION)
FIGURE 12 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN IMMUNOCHEMISTRY 2017-2026 ($ MILLION)
FIGURE 13 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN MOLECULAR DIAGNOSTICS 2017-2026 ($ MILLION)
FIGURE 14 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN HEMATOLOGY/HEMOSTASIS 2017-2026 ($ MILLION)
FIGURE 15 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN POINT-OF-CARE TESTING 2017-2026 ($ MILLION)
FIGURE 16 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN ORTHOPAEDICS AND SPINE 2017-2026 ($ MILLION)
FIGURE 17 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN RECONSTRUCTIVE IMPLANTS 2017-2026 ($ MILLION)
FIGURE 18 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN SPINAL IMPLANTS 2017-2026 ($ MILLION)
FIGURE 19 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN TRAUMA FIXATION DEVICES 2017-2026 ($ MILLION)
FIGURE 20 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN ORTHOPEDIC ROBOTIC SYSTEMS 2017-2026 ($ MILLION)
FIGURE 21 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN IMAGING DEVICES 2017-2026 ($ MILLION)
FIGURE 22 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN X-RAY SYSTEMS 2017-2026 ($ MILLION)
FIGURE 23 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN ULTRASOUND SYSTEMS 2017-2026 ($ MILLION)
FIGURE 24 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN COMPUTED TOMOGRAPHY (CT) 2017-2026 ($ MILLION)
FIGURE 25 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS 2017-2026 ($ MILLION)
FIGURE 26 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN CLINICAL/POINT OF CARE 2017-2026 ($ MILLION)
FIGURE 27 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN NUCLEAR MEDICINE/POSITRON EMISSION TOMOGRAPHY (PET) 2017-2026 ($ MILLION)
FIGURE 28 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN INTERVENTIONAL RADIOLOGY 2017-2026 ($ MILLION)
FIGURE 29 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN 2017-2026 ($ MILLION)
FIGURE 30 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN CARDIOVASCULAR DEVICES 2017-2026 ($ MILLION)
FIGURE 31 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN CARDIAC RHYTHM MANAGEMENT 2017-2026 ($ MILLION)
FIGURE 32 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN TRANSCATHETER TECHNOLOGIES 2017-2026 ($ MILLION)
FIGURE 33 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN ENDOSCOPY 2017-2026 ($ MILLION)
FIGURE 34 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN RIGID ENDOSCOPIC 2017-2026 ($ MILLION)
FIGURE 35 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN FLEXIBLE ENDOSCOPIC 2017-2026 ($ MILLION)
FIGURE 36 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN ASCS 2017-2026 ($MILLION)
FIGURE 37 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN HOSPITAL 2017-2026 ($MILLION)
FIGURE 38 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET IN PHYSICIANS OFFICES 2017-2026 ($MILLION)
FIGURE 39 NORTH AMERICA SURGICAL AND MEDICAL DEVICE MARKET 2017-2026 ($ MILLION)
FIGURE 40 UNITED STATES SURGICAL AND MEDICAL DEVICE MARKET 2017-2026 ($ MILLION)
FIGURE 41 CANADA SURGICAL AND MEDICAL DEVICE MARKET 2017-2026 ($ MILLION)
COMPANIES MENTIONED
1. 3M COMPANY
2. ABBOTT LABORATORIES
3. AGILENT TECHNOLOGIES
4. BAYER
5. BAXTER INTERNATIONAL
6. BECKTON, DICKINSON, AND CO.
7. BOSTON SCIENTIFIC
8. CARDINAL HEALTH
9. CRYOLIFE INC.
10. DANAHER
11. DEPUY SYNTHES
12. ENDOLOGIX INC.
13. FRESENIUS
14. GE HEALTHCARE
15. HALYARD HEALTH, INC.
16. JOHNSON & JOHNSON
17. MEDTRONIC
18. NOVARTIS
19. OLYMPUS CORPORATION
20. PHILIPS HEALTHCARE
21. ROCHE DIAGNOSTICS
22. SIEMENS HEALTHCARE
23. SMITH & NEPHEW
24. STRYKER CORP.
25. TELEFLEX
26. THERMO FISHER SCIENTIFIC
27. TOSHIBA MEDICAL SYSTEMS CORP. (CANON)
28. ZIMMER HOLDINGS
